TREM2 and neoplasm: Clinicopathological analysis revealed that TREM2 downregulation was significantly correlated with aggressive pathological features, like BCLC stage, tumor size, tumor encapsulation, vascular invasion and tumor differentiation (Supplementary Table 2).